Charles River Laboratories International (CRL) Non Operating Interest Expenses (2009 - 2026)

Charles River Laboratories International has reported Non Operating Interest Expenses for 18 years, with the latest figure at $30.3 million in Q2 2026.

• On a quarterly basis, Non Operating Interest Expenses rose 1.24% year-over-year to $30.3 million in Q2 2026; TTM through Jun 2026 was $106.3 million, a 8.69% decrease from a year earlier, with the FY2025 full-year figure at $107.0 million, down 15.25% from the prior year.
• Non Operating Interest Expenses was $30.3 million for Q2 2026 at Charles River Laboratories International, up from $26.7 million in the prior quarter.
• The five-year high for Non Operating Interest Expenses was $35.0 million in Q3 2023, with the low at $3.7 million in Q2 2022.
• Average Non Operating Interest Expenses over 5 years is $27.0 million, with a median of $30.1 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2023: Non Operating Interest Expenses slumped 77.13% in 2022, then surged 846.37% in 2023.
• Over 5 years, Non Operating Interest Expenses stood at $34.8 million in 2022, then fell by 3.55% to $33.5 million in 2023, then declined by 15.83% to $28.2 million in 2024, then fell by 15.79% to $23.8 million in 2025, then advanced by 27.61% to $30.3 million in 2026.
• The last three Non Operating Interest Expenses figures came in at $30.3 million (Q2 2026), $26.7 million (Q1 2026), and $23.8 million (Q4 2025), per Business Quant data.